PATENT CLAIM ANALYSIS

Application Number: 15924511
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to a truncated L1 protein of the Human Papillomavirus Type 11, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.

Claim (Index 14):
A N-terminally truncated HPV11 L1 protein consisting of SEQ ID NO.: 2.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.48387
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15350264', '12601972', '14248063', '12601983', '12598187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8843471962746979
- 35 USC 102 Novelty (BERT): 0.686049855901759
- Combined Prediction Score: 0.8645174622374041
- Mean Citation Score: 748.287266
- Max Citation Score: 797.6519
- Similarity Product: 687.4907302569867

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test